Long-term follow up of unilateral deep brain stimulation for Parkinson’s disease
Objective: To assess long-term effectiveness of unilateral Deep Brain Stimulation (DBS) in Parkinson’s disease (PD) patients with up to 14 months of follow-up Background: DBS…Early Outcomes Support use of a Remote Cross-Border Surgical Centre for Deep Brain Stimulation in Parkinson’s Disease
Objective: We describe the results of a unique cross border collaboration to deliver BDS for Parkinson's disease in Ireland. Background: Deep brain stimulation (DBS) of…Video-based Machine Rating Model for MDS-UPDRS III in Parkinson’s disease: A Proof-of-concept Pilot Study
Objective: To develop a video-based machine rating system for the Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) III. Background: MDS-UPDRS III…Reliability of real-world walking activity and gait assessment in people with Parkinson’s disease – how many hours and days are needed?
Objective: To define i) the minimally required daily wear time during waking hours that constitutes a valid measurement of walking using digital mobility outcomes (DMOs)…Prediction of falls in PD over 5 years using kinematic data and machine learning
Objective: This study aims to evaluate the potential of a wearable sensor-based walking and balance assessment to predict the risk of falling in individuals with…Distinguishing Parkinson’s disease from atypical Parkinsonian syndrome using multistage deep learning based on dopamine transporter imaging
Objective: We made the diagnostic model using a deep learning algorithm based on dopamine transporterWe made the diagnostic model using a deep learning algorithm based…Candidate biomarkers of EV-microRNA in detecting REM sleep behavior disorder and Parkinson’s disease
Objective: Accessible and reliable biomarkers for early diagnosis of PD and iRBD are urgently needed to identify candidate therapeutic targets and to monitor disease progression…Association between Genetic Polymorphisms and Disease Progression in Parkinson’s disease
Objective: In this study, we aim to elucidate the association between the various haplotypes of the Catechol-O-methyltransferase (COMT) and Monoamine oxidase B (MAO-B) genes, the…Causal effects of sarcopenia-related traits on risk and progression of Parkinson’s disease: a Mendelian randomization study
Objective: To examine causal associations between sarcopenia-related traits and the risk or progression of Parkinson’s disease (PD) using a Mendelian randomization (MR) approach. Background: Previous…RAB32 variant p.Ser71Arg in the ROstock PArkinson’s Disease Study (ROPAD)
Objective: To identify and characterize PD patients with RAB32 variant p.Ser71Arg in the ROstock PArkinson’s Disease Study (ROPAD; ClinicalTrials.gov NCT03866603). Background: A recent preprint provided…
- « Previous Page
- 1
- …
- 69
- 70
- 71
- 72
- 73
- …
- 338
- Next Page »